DUBLIN--(BUSINESS WIRE)--The "Animal
Parasiticides - Global Market Outlook (2017-2023)" report has
been added to ResearchAndMarkets.com's offering.
The
Global Animal Parasiticides market is accounted for $7.54 billion in
2016 and is expected to reach $11.63 billion by 2023 growing at a CAGR
of 6.3%.
Increasing awareness among people about zoonotic
disease and rising adoption of pet animals largely across the globe has
made a way for the global animal parasiticide market. With the rise in
animal health expenditure, animal-derived food products and animal
research along with growing research grants, the market is fueling up.
However,
preferential adoption of vegetarian diets, stringent approval process
for animal parasiticides and restriction on the use of parasiticides in
food-producing animals are restraining the market to a certain extent.
Based
on product, the demand for endoparasiticides products are growing more
and more as they manage the incidences of internal parasiticides such as
flukes, tapeworms and roundworms which in turns favors the market.
Segments
Covered
Product Types
- Ectoparasiticides Products
- Collars
- Ear Tags
- Pour-on and Spot-on
- Sprays
- Oral Tablets
- DIPS
- Other Ectoparasiticide Products
- Endoparasiticides Products
- Injectables
- Oral
- Feed Additives
- Other Endoparasiticide Products
- Endectocides Products
Animal Types
- Companion Animals
- Dogs
- Cats
- Horses
- Other Companion Animals
- Farm Animals
- Poultry
- Cattle
- Pigs
- Sheep and Goats
- Fish
- Other Farm Animals
Disease-Causing Organisms
- Ectoparasiticides
- Mites
- Fleas
- Lice
- Endoparasiticides
- Fleas
- Mites
- Lice
Key Topics Covered
1 Executive Summary
2
Preface
3 Market Trend Analysis
4 Porters Five
Force Analysis
5 Global Animal Parasiticides Market, By
Product
6 Global Animal Parasiticides market, By Animal Type
7
Global Animal Parasiticides market, By Disease Causing Organism
8
Global Animal Parasiticides Market, By Geography
9 Key
Developments
10 Company Profiling
- Novartis AG
- ELI Lilly and Company
- Virbac SA
- Perrigo Company PLC
- Ceva Sante Animale
- Boehringer Ingelheim
- Merck & Co. Inc.
- Bayer AG
- Zoetis, Inc.
- Elanco
- Vetoquinol S.A.
- Sanofi S.A
- Dechra Pharmaceuticals
- Lillidale Animal Health
- Phibro Animal Health
For more information about this report visit https://www.researchandmarkets.com/research/p3tsd2/global_animal?w=4
